The Cleveland Clinic Foundation

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1921-01-01

Employees: 1K

Market Cap: -

Website: http://www.clevelandclinic.org

Clinical Trials

Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis

Not Applicable

Withdrawn

Conditions: Cirrhosis
Ascites
End Stage Liver Disease
Hypotension

Interventions: Drug: Midodrine

First Posted Date: 2011-04-08

Last Posted Date: 2013-07-31

Lead Sponsor: The Cleveland Clinic

Registration Number: NCT01331785

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

Biomarkers in Pulmonary Arterial Hypertension Treated With Nilotinib

Withdrawn

Conditions: PAH

First Posted Date: 2011-03-23

Last Posted Date: 2014-02-04

Lead Sponsor: The Cleveland Clinic

Registration Number: NCT01320865

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches

Not Applicable

Completed

Conditions: Migraine Headache

Interventions: Device: Deep Brain Stimulation of SPG for Migraine

First Posted Date: 2011-02-11

Last Posted Date: 2017-04-14

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 3

Registration Number: NCT01294046

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

Fospropofol for Sedation During Elective Awake Intubation

Not Applicable

Withdrawn

Conditions: Impaired Airway Clearance

Interventions: Drug: fospropofol

First Posted Date: 2011-02-03

Last Posted Date: 2017-04-18

Lead Sponsor: The Cleveland Clinic

Registration Number: NCT01289483

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty

Not Applicable

Completed

Conditions: Arthritis

Interventions: Device: Vitagel

First Posted Date: 2011-01-27

Last Posted Date: 2017-04-11

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 109

Registration Number: NCT01285024

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis

Not Applicable

Completed

Conditions: Adult Growth Hormone Deficiency
Hypothalamic-pituitary Disorders

Interventions: Procedure: glucagon stimulation test and insulin tolerance test

First Posted Date: 2011-01-24

Last Posted Date: 2017-05-17

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 43

Registration Number: NCT01282164

Locations: 🇺🇸
Allegheny Endocrinology Associates, Pittsburgh, Pennsylvania, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Cleveland Clinic Endocrinology, Diabetes and Metabolism, Cleveland, Ohio, United States

and more 1 locations

Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes

Not Applicable

Completed

Conditions: Obesity
Type 2 Diabetes

Interventions: Procedure: laparoscopic roux en y gastric bypass operation
Other: medical management

First Posted Date: 2011-01-19

Last Posted Date: 2019-07-11

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 18

Registration Number: NCT01278823

Locations: 🇺🇸
Cleveland Clinic Bariatric and Metabolic Institute, Department of Pathobiology, Cleveland, Ohio, United States

A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain

Not Applicable

Completed

Conditions: Adult Intracranial Tumor
Adult Solid Tumor

Interventions: Drug: Remifentanil
Drug: Dexmedetomidine

First Posted Date: 2011-01-04

Last Posted Date: 2016-12-20

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 142

Registration Number: NCT01269918

Locations: 🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States

Face Transplantation Clinical Trial

Not Applicable

Completed

Conditions: Severe Facial Deformities

Interventions: Procedure: Surgical Procedure Composite Facial Transplant

First Posted Date: 2011-01-04

Last Posted Date: 2023-08-31

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 3

Registration Number: NCT01269164

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States

Alefacept in Patients With Relapsed/Refractory Aplastic Anemia

Phase 1

Terminated

Conditions: Aplastic Anemia

Interventions: Drug: Alefacept

First Posted Date: 2010-12-28

Last Posted Date: 2018-01-26

Lead Sponsor: The Cleveland Clinic

Target Recruit Count: 4

Registration Number: NCT01267643

Locations: 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy